Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Cambridge Research & Instrumentation Inc. (CRi)

Nov 2006
Cambridge Research & Instrumentation Inc. (CRi) of Woburn, Mass., and Invitrogen Corp. of Carlsbad, Calif., have agreed to jointly promote CRi’s Maestro in vivo fluorescence imaging system with Invitrogen subsidiary Molecular Probes’ Saivi and Qtracker in vivo reagents. The reagents are used in small-animal modeling studies for diseases such as cancer. Combining the labeling technologies with the imaging system could facilitate identification of diseased cell populations.

The California company separately announced the asset purchase of fluo 3 and fluo 4 product lines and all related intellectual property from TEF Labs Inc. of Austin, Texas. The acquisition will enable it to manufacture and sell the fluorescent indicators used to measure the concentration of calcium ions in living cells.


Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!